Search for: "TEVA PHARMACEUTICAL USA, INC."
Results 341 - 360
of 483
Sort by Relevance
|
Sort by Date
6 Jul 2011, 2:21 am
Biopet Vet Lab, Inc., et. al. [read post]
27 Jun 2011, 8:41 am
” Certiorari stage documents: Opinion below (3d Circuit) Petition for certiorari Brief in opposition Petitioners’ supplemental brief Respondents’ supplemental brief Petitioners’ reply Amicus brief of TEVA Pharmaceuticals USA, Inc. [read post]
24 Jun 2011, 3:25 pm
”Certiorari stage documents:Opinion below (3d Circuit)Petition for certiorariBrief in oppositionPetitioners' supplemental briefRespondents' supplemental briefPetitioners' replyAmicus brief of TEVA Pharmaceuticals USA, Inc.Amicus brief of Consumer Federation of America et al.Amicus brief of Mylan Pharmaceuticals, Inc.Amicus brief of Apotex, Inc.Amicus Generic Pharmaceutical AssociationCVSG Information:Invited: March 28, 2011Filed: May… [read post]
14 Jun 2011, 12:21 pm
Teva Pharmaceuticals USA, Inc., 10-1070, in which the Court had relisted twice and called for a response. [read post]
7 Jun 2011, 12:30 pm
Certiorari stage documents:Opinion below (2d Circuit)Petition for certiorariBrief in opposition of Steinbeck Heritage Foundation/Estate RespondentsPetitioners' replyAmicus brief of Graphic Artists Guild et al.Amicus brief of Penguin Group (USA), Inc. [read post]
7 Jun 2011, 10:12 am
Teva Pharmaceuticals USA, Inc., 10-1070 (second relist since the Court called for a response). [read post]
2 Jun 2011, 12:46 pm
Ortho Pharmaceutical Corp., 681 P.2d 1038, 1052 (Kan. 1984). [read post]
2 Jun 2011, 6:02 am
Teva Pharmaceuticals USA, Inc., 10-1070, which we included in last week’s Petitions to Watch. [read post]
1 Jun 2011, 5:51 pm
Karst – Last week, in a seven-page response, FDA denied an October 18, 2010 Citizen Petition submitted on behalf of Lupin Limited (“Lupin”) requesting that FDA determine that Teva Pharmaceuticals USA, Inc. [read post]
27 May 2011, 8:56 am
”Certiorari stage documents:Opinion below (3d Circuit)Petition for certiorariBrief in oppositionPetitioners' replyAmicus brief of TEVA Pharmaceuticals USA, Inc.Amicus brief of Consumer Federation of America et al.Amicus brief of Mylan Pharmaceuticals, Inc.Amicus brief of Apotex, Inc.Amicus Generic Pharmaceutical AssociationCVSG Information:Invited: March 28, 2011Filed: May 26, 2011 (Grant) Title: National Meat Association v. [read post]
23 May 2011, 9:59 pm
• Defendants: Impax Laboratories, Inc.; Teva Pharmaceuticals USA, Inc.; Teva Pharmaceutical Industries Ltd. [read post]
23 May 2011, 4:00 am
Teva Pharmaceuticals USA Inc., 2011 U.S. [read post]
22 May 2011, 8:41 pm
• Defendant: Teva Pharmaceuticals USA, Inc. [read post]
15 May 2011, 8:55 pm
• Defendant: Teva Pharmaceuticals USA Inc. [read post]
21 Apr 2011, 1:36 pm
Teva Pharmaceuticals USA, Inc., 2007 WL 5787186 (S.D. [read post]
13 Apr 2011, 5:13 pm
Ortho-McNeil-Janssen Pharmaceuticals, Inc., No. 2-10-cv-00836 (E.D. [read post]
6 Apr 2011, 12:18 am
427/09 Generics (UK) Ltd v Synaptech Inc (The SPC Blog) Simcor (Niacin, Simvastatin) – US: Abbott files patent infringement complaint against Watson following Para IV certification filing (Patent Docs) Thalomid (Thalidomide) – US: Decision in Lannett Thalomid bioequivalence study sample antitrust lawsuit could reignite debate on generic drug availability and REMS restrictions (FDA Law Blog) Yasmin (Drospirenone, Ethinylestradiol) – UK: Bayer Yasmin patents survive patent… [read post]
5 Apr 2011, 2:35 pm
Par opposed the Motion to Dismiss arguing that pursuant to the Federal Circuit’s decision in Teva Pharmaceuticals USA, Inc. v. [read post]
24 Mar 2011, 12:53 pm
”Certiorari stage documents:Opinion below (3d Circuit)Petition for certiorariBrief in oppositionPetitioners' replyAmicus brief of TEVA Pharmaceuticals USA, Inc.Amicus brief of Consumer Federation of America et al.Amicus brief of Mylan Pharmaceuticals, Inc.Amicus brief of Apotex, Inc.Amicus Generic Pharmaceutical Association Title: Stovall v. [read post]
22 Mar 2011, 4:21 pm
: Board of Trustees of Leland Stanford Junior University v Roche Molecular Systems Inc (IPKat) US: That was unexpectedly… well… expected: BPAI affirms Examiner’s obviousness rejection in Ex Parte Akio Ochiai concerning a health food product containing curcumin, scymnol and isoflavones (BT-IP Notes) US: VirginiaTech VERSUS series – Drug evaluation DVDs available (FDA Law Blog) Products Diovan HCT (Valsartan, Hydrochlorothiazide) – Germany:… [read post]